Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Compatibility Of Medroxyprogesterone Acetate And Pharmaceutical Excipients Through Thermal And Spectroscopy Techniques
Published 2014 · Materials Science
Studies of active drug-excipient compatibility represent an important phase in the preformulation stage of the development of all dosage forms. For the development of conjugation estrogens and medroxyprogesterone acetate (MPA) double-layer tablets, techniques of thermal, isothermal stress testing (IST), and molecular vibrational spectroscopy analysis were performed to access the compatibility. Differential scanning calorimetry (DSC) studies were used as an important and complementary tool during preformulation to determine drug-excipient compatibility. On the basis of DSC results, MPA was found to be compatible with polyethylene glycol 6000. However, the results of Raman and IST studies showed that all the excipients defined in the prototype formula were found to be compatible with MPA. Overall, the compatibility of selected excipients with MPA was successfully evaluated using a combination of thermal and IST methods, and the formulations developed using the compatible excipients were found to be stable.